Browse the evidence

Overweight status (including obesity) is the fourth most common risk factor for non-communicable chronic diseases.

This highlights the importance of addressing obesity in public health initiatives aimed at reducing chronic disease risk.

Metabolic health, rather than obesity, is a key predictor of adverse events in chronic coronary syndrome (CCS) prevention.

Practitioners should prioritize assessing metabolic health over BMI in cardiovascular risk evaluations.

Tirzepatide and cagrilintide-semaglutide are promising agents for adjunctive pharmacological management of weight gain in SMI.

Practitioners should consider these new agents as potential options for managing weight gain in SMI patients.

Approximately 80% of subjects had cholesterol levels outside recommended values after 6 years.

Monitoring cholesterol levels is important for older adults, even after exercise interventions.

Subjects were less hypo hydrated after consuming high sodium compared to lower sodium concentrations.

High sodium intake may help athletes maintain better hydration levels during extended exercise.

There is a need to address perceived barriers to maintaining healthy behaviors to plan future activities.

Future interventions should consider the barriers identified to improve health promotion efforts.

Bariatric surgery has emerged as an effective treatment for obesity.

Bariatric surgery can be considered a viable option for treating obesity in patients.

Low-carb diet (LCD) resulted in lower morning postprandial, noon postprandial, and evening preprandial capillary blood sugar levels.

Implementing a low-carb diet may help improve glycemic control in late pubertal girls with type 1 diabetes.

LCD was associated with lower carbohydrate consumption and rapidly acting insulin dose.

A low-carb diet may reduce the need for insulin in managing type 1 diabetes.

LCD may provide better glycemic control and is favorable for weight control and atherosclerosis prevention.

Adopting a low-carb diet could be beneficial for managing diabetes and preventing related health issues.

The enhancement in performance was less (0.7%) for cyclists not told what was in the drink compared to those told carbohydrate.

Awareness of the drink's contents can influence performance outcomes.

Naproxen treatment resulted in a statistically significant treatment effect for workload compared to placebo.

Naproxen may enhance workload capacity during high-intensity strength training.

Naproxen treatment resulted in a lower fatigue index (FI) compared to the first set of exercises.

Naproxen may help reduce fatigue during strength training sessions.

Greater readiness to change behavior is associated with a better health profile in women.

Encouraging readiness to change may enhance health outcomes, particularly in women.

Dietary guidelines for people with diabetes are not designed for rural areas where healthcare resources are scarce.

Healthcare professionals should consider the limitations of existing dietary guidelines when working with underserved populations.

Potential solutions to guideline gaps are proposed to aid in providing nutritional therapy for the underserved.

Implementing proposed solutions can enhance nutritional therapy for underserved individuals with diabetes.

Most individuals regularly involved in physical activity have decent nutritional awareness due to counseling from coaches.

Coaches should continue to provide nutritional counseling to enhance athletes' awareness.

Gait speeds increased and Get Up and Go times decreased in the women who completed 6 months of counseling.

Counseling can improve physical performance metrics in women.

Changes in dietary patterns are influenced by factors such as food availability, lifestyle, and educational level.

Policies aimed at improving dietary habits should consider these influencing factors.

Glucagon-like 1 receptor antagonists and sodium-glucose co-transporter 2 inhibitors play a role in secondary prevention of atherosclerotic cardiovascular disease.

These agents may be recommended for secondary prevention in diabetic patients with cardiovascular risks.

Whole-fat dairy is unlikely to augment hypertensive risk when added to the normal routine diet.

Whole-fat dairy may be included in diets without increasing hypertensive risk.

Non- and low-fat dairy products are effective in reducing elevated blood pressure and improving vascular functions.

Encouraging non- and low-fat dairy consumption may be beneficial for blood pressure management.

90% of primary care physicians reported that being overweight increases mortality risk.

Practitioners should be aware that a significant majority of their peers believe overweight contributes to increased mortality risk.

Participants' median vignette-elicited risk ratio was 1.25, indicating a perceived 25% increased mortality risk associated with being overweight.

This finding can help practitioners understand how perceptions of risk can vary based on context.